Health-care companies fell slightly amid mixed earnings prospects.

Taiwan's leading eye-care companies such as Universal Vision Biotechnology and Pegavision are likely to emerge as major beneficiaries of China's reopening, said analysts at brokerage Citi.


Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

01-17-23 1659ET